![Roy Pettipher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roy Pettipher
Technik-/Wissenschafts-/F&E-Leiter bei
Atopix Therapeutics Ltd.
Profil
Roy Pettipher was the founder of Orca Pharmaceuticals Ltd. since 2012, holding the title of Chief Scientific Officer.
Current job includes Research Director at Atopix Therapeutics Ltd. Former jobs include Pharmacology Director at Oxagen Ltd., Principal at Pfizer Inc., and Principal at Wellcome Plc.
Aktive Positionen von Roy Pettipher
| Unternehmen | Position | Beginn |
|---|---|---|
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel class of medicines to treat atopic dermatitis and severe asthma | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Roy Pettipher
| Unternehmen | Position | Ende |
|---|---|---|
Orca Pharmaceuticals Ltd.
 Orca Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops oral drugs for the treatment of chronic inflammatory disease | Gründer | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Corporate Officer/Principal | - |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Orca Pharmaceuticals Ltd.
Orca Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops oral drugs for the treatment of chronic inflammatory disease | Health Technology |
Wellcome Plc
Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Operates as a charitable foundation for healthcare | Commercial Services |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Atopix Therapeutics Ltd.
Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops a novel class of medicines to treat atopic dermatitis and severe asthma | Health Technology |
